HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Qiao Yang Selected Research

Nasopharyngeal Carcinoma

1/2023Expression of cytoskeleton-associated protein 4 is associated with poor prognosis and metastasis in nasopharyngeal carcinoma.
1/2022Gemcitabine Combined with Cisplatin Has a Better Effect in the Treatment of Recurrent/Metastatic Advanced Nasopharyngeal Carcinoma.
1/2022Expression of Programmed Death Ligand-2 is associated with Prognosis in Nasopharyngeal Carcinoma Microenviroment.
10/2021A randomized, controlled phase II trial of maxillofacial and oral massage in attenuating severe radiotherapy-induced oral mucositis and lipid metabolite changes in nasopharyngeal carcinoma.
2/2014[Analysis of the nutritional status and nosocomial infection during chemoradiotherapy in advanced nasopharyngeal carcinoma patients].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Qiao Yang Research Topics

Disease

75Infections
02/2024 - 03/2013
36Plague (Bubonic Plague)
01/2024 - 01/2016
30Neoplasms (Cancer)
08/2024 - 11/2014
28Virus Diseases (Viral Diseases)
05/2024 - 11/2015
16Enteritis
01/2021 - 05/2012
11Inflammation (Inflammations)
12/2024 - 06/2007
9Liver Cirrhosis (Hepatic Cirrhosis)
05/2024 - 06/2008
7Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2022 - 01/2018
7Bites and Stings (Sting)
03/2022 - 01/2018
6Fibrosis (Cirrhosis)
05/2024 - 09/2017
6Flavivirus Infections
01/2023 - 01/2017
6Melanoma (Melanoma, Malignant)
03/2022 - 03/2007
5Nasopharyngeal Carcinoma
01/2023 - 02/2014
4Neoplasm Metastasis (Metastasis)
01/2023 - 11/2014
4Liver Diseases (Liver Disease)
01/2023 - 05/2010
4Hypoxia (Hypoxemia)
01/2023 - 04/2006
3Osteoporosis
02/2024 - 08/2021
3Necrosis
01/2024 - 03/2010
3Asthma (Bronchial Asthma)
01/2023 - 01/2022
3Hemorrhage
01/2022 - 04/2015
3Chronic Hepatitis B
06/2021 - 03/2015
3Shellfish Poisoning
07/2020 - 09/2019
3Herpes Simplex
01/2020 - 11/2015
3Acquired Hyperostosis Syndrome (SAPHO Syndrome)
01/2019 - 06/2018
3Influenza in Birds (Avian Flu)
12/2016 - 01/2016
2Uterine Cervical Neoplasms (Cancer of the Cervix)
03/2024 - 11/2014
2Stomach Neoplasms (Stomach Cancer)
02/2024 - 01/2022
2Fatigue
01/2024 - 08/2021
2Hepatocellular Carcinoma (Hepatoma)
10/2023 - 01/2021
2Alzheimer Disease (Alzheimer's Disease)
07/2022 - 08/2021
2Viremia
05/2022 - 01/2017
2Stroke (Strokes)
05/2022 - 01/2003
2Lung Neoplasms (Lung Cancer)
01/2022 - 01/2019
2Porcine Reproductive and Respiratory Syndrome (PRRS)
11/2021 - 01/2020
2COVID-19
09/2021 - 08/2021
2Obesity
08/2021 - 06/2007

Drug/Important Bio-Agent (IBA)

61Proteins (Proteins, Gene)FDA Link
02/2024 - 03/2013
28Antiviral Agents (Antivirals)IBA
01/2024 - 01/2015
18VaccinesIBA
12/2023 - 10/2015
14Messenger RNA (mRNA)IBA
01/2024 - 11/2014
13RNA (Ribonucleic Acid)IBA
02/2023 - 12/2016
12CytokinesIBA
01/2024 - 01/2015
11Biomarkers (Surrogate Marker)IBA
03/2024 - 01/2015
11InterferonsIBA
11/2023 - 01/2016
9butyl phosphorotrithioate (DEF)IBA
01/2024 - 01/2017
9Interferon Type IIBA
11/2023 - 01/2016
8DNA (Deoxyribonucleic Acid)IBA
01/2024 - 01/2018
8Viral ProteinsIBA
01/2024 - 01/2020
8Immune Checkpoint InhibitorsIBA
10/2023 - 01/2018
7Glycoproteins (Glycoprotein)IBA
05/2023 - 01/2018
6Phosphotransferases (Kinase)IBA
05/2023 - 07/2015
6LipidsIBA
10/2021 - 03/2010
5MicroRNAs (MicroRNA)IBA
09/2023 - 11/2017
4Interleukin-6 (Interleukin 6)IBA
04/2024 - 03/2016
4LipopolysaccharidesIBA
12/2022 - 07/2015
4Peptide Hydrolases (Proteases)FDA Link
01/2022 - 11/2017
4anandamide (arachidonylethanolamide)IBA
05/2010 - 06/2008
3AntioxidantsIBA
08/2024 - 08/2021
3Interleukin-2 (IL2)IBA
01/2024 - 11/2021
3Nuclear Localization Signals (Nuclear Localization Signal)IBA
01/2024 - 01/2016
3Anti-Bacterial Agents (Antibiotics)IBA
12/2023 - 01/2015
3Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
10/2023 - 10/2020
3Protein Kinases (Protein Kinase)IBA
03/2023 - 01/2021
3Etoposide (VP 16)FDA LinkGeneric
02/2023 - 01/2016
3OvalbuminIBA
01/2023 - 01/2022
3Carrier Proteins (Binding Protein)IBA
01/2023 - 11/2014
3Toll-Like Receptor 3IBA
01/2023 - 01/2020
3Attenuated VaccinesIBA
03/2022 - 01/2018
3Therapeutic UsesIBA
02/2022 - 08/2019
3Tyrosine Kinase InhibitorsIBA
01/2022 - 01/2019
3Poly I-CIBA
01/2022 - 01/2016
3Staphylococcal Protein A (Protein A)IBA
01/2021 - 01/2017
3Coloring Agents (Dyes)IBA
07/2020 - 03/2010
3ODN2006IBA
01/2017 - 01/2016
3EndocannabinoidsIBA
05/2010 - 06/2008
2Polysaccharides (Glycans)IBA
08/2024 - 02/2024
2Interleukin-8 (Interleukin 8)IBA
04/2024 - 01/2024
2Interferon-gamma (Interferon, gamma)IBA
01/2024 - 01/2016
2Interleukin-4 (Interleukin 4)IBA
01/2024 - 11/2021
2Reactive Oxygen Species (Oxygen Radicals)IBA
01/2024 - 07/2022
2Viral RNAIBA
01/2024 - 01/2020
2TNF Receptor-Associated Factor 3IBA
11/2023 - 12/2016
268Ga-FAPIIBA
10/2023 - 05/2022
2Methylene Chloride (Dichloromethane)IBA
01/2023 - 01/2022
2Anti-Allergic Agents (Antiallergic Agents)IBA
01/2023 - 01/2022
2Oxygen (Dioxygen)IBA
01/2023 - 08/2009
2Cadherins (E-Cadherin)IBA
01/2023 - 01/2022
2Erlotinib Hydrochloride (CP 358,774)FDA Link
12/2022 - 01/2019
23' Untranslated Regions (3' UTR)IBA
10/2022 - 01/2020
2Caspase 3 (Caspase-3)IBA
07/2022 - 01/2022
2AntibodiesIBA
05/2022 - 01/2020
2CaspasesIBA
01/2022 - 01/2019
2Cisplatin (Platino)FDA LinkGeneric
01/2022 - 01/2022
26-methyladenineIBA
01/2022 - 01/2022

Therapy/Procedure

19Therapeutics
05/2024 - 06/2007
6Radiotherapy
01/2024 - 01/2019
3Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2024 - 01/2020
3Aftercare (After-Treatment)
12/2023 - 01/2022
3Drug Therapy (Chemotherapy)
01/2023 - 11/2020
3Continuous Positive Airway Pressure
07/2008 - 04/2006